Director’s Messages from 2021

In this Director’s message, Dr. Gordon and Dr. Koroshetz, director of the National Institute of Neurological Disorders and Stroke, discuss the first major product to result from the Brain Initiative Cell Census Network, a comprehensive description of the cell types in the motor cortex of mice, monkeys, and humans.

In this jointly written Director’s Message, Dr. Gordon and Dr. Rachel L. Levine, HHS Assistant Secretary for Health, describe the mental health impacts of the COVID pandemic on children and what we can do to support kids during this difficult time.

In this jointly written Director’s Message, NIMH director Dr. Joshua Gordon and Dr. Maureen Goodenow, associate director for AIDS Research and director of the Office of AIDS Research at the National Institutes of Health, discuss 40 years of NIMH and NIH support for HIV/AIDS research.

In this message for Autism Awareness Month, Dr. Gordon highlights the specific impacts that the COVID-19 pandemic has had for individuals on the autism spectrum and their families.

In this message, Dr. Gordon highlights what we know about Americans’ mental health after one year of the COVID-19 pandemic.

In this jointly written Director’s Message, leadership from across NIH describes one year of progress made through the RADx initiative and anticipates new challenges in the fight against COVID-19.

In this message for National Eating Disorder Awareness Week, Dr. Gordon highlights NIMH-funded research aimed at reducing the impact of eating disorders.

In this jointly written Director’s Message, leadership from across NIH encourages the neuroscience community to take advantage of the new NIH-wide FIRST Program, which aims to enhance cultures of inclusive excellence through institutional support for recruitment of diverse “cohorts” of early-stage research faculty.

In Dr. Gordon’s latest Director’s Message, he expresses support for the critical work of NIMH’s Dr. Elisabeth Murray and others who are advancing brain science through basic research.